AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer ...
We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...